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Abstract
Background: The study was designed to evaluate whether the preserved coronary flow reserve (CFR) 72 hours
after reperfused acute myocardial infarction (AMI) is associated with less microvascular dysfunction and is predictive
of left ventricular (LV) functional recovery and the final infarct size at follow-up.
Methods: In our study, CFR was assessed by transthoracic Doppler echocardiography (TDE) in 44 patients after the
successful percutaneous coronary intervention during the acute AMI phase. CFR was correlated with contractile
reserve assessed by low-dose dobutamine echocardiography and with the total perfusion defect measured by
single-photon emission computed tomography 72 hours after reperfusion and at 5 months follow-up. The ROC
analysis was performed to determine test sensitivity and specificity based on CFR. Categorical data were compared
by an c
2 analysis, continuous variables were analysed with the independent Student’s t test. In order to analyse
correlation between CFR and the parameters of LV function and perfusion, the Pearson correlation analysis was
conducted. The linear regression analysis was used to assess the relationship between CFR and myocardial
contractility as well as the final infarct size.
Results: We estimated the CFR cut-off value of 1.75 as providing the maximal accuracy to distinguish between
patients with preserved and impaired CFR during the acute AMI phase (sensitivity 91.7%, specificity 75%). Wall
motion score index was better in the subgroup with preserved CFR as compared to the subgroup with reduced
CFR: 1.74 (0.29) vs. 1.89 (0.17) (p < 0.001) during the acute phase and 1.47 (0.30) vs. 1.81 (0.20) (p < 0.001) at
follow-up, respectively. LV ejection fraction was 47.78% (8.99) in preserved CFR group vs. 40.79% (7.25) in impaired
CFR group (p = 0.007) 72 hours after reperfusion and 49.78% (8.70) vs. 40.36% (7.90) (p = 0.001) after 5 months at
follow-up, respectively. The final infarct size was smaller in patients with preserved as compared to patients with
reduced CFR: 5.26% (6.14) vs. 23.28% (12.19) (p < 0.001) at follow-up.
Conclusion: The early measurement of CFR by TDE can be of high value for the assessment of successful
reperfusion in AMI and can be used to predict LV functional recovery, myocardial viability and the final infarct size.
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Early and successful percutaneous coronary intervention
(PCI) is the most effective and preferred reperfusion
strategy for treating ST-elevation AMI (STEMI), redu-
cing the infarct size and improving the clinical out-
comes. The achievement of an adequate tissue level
(myocardial) perfusion is the goal of reperfusion therapy.
Nevertheless, myocardial damage is not terminated
immediately, even in successful primary PCI with
Thrombolysis In Myocardial Infarction (TIMI) flow
grade 3 in the infarct-related artery (IRA) [1]. Paradoxi-
cally, the restoration of blood flow to the ischaemic
myocardium can result in additional cardiac damage
and complications, since the introduction of oxygen and
energy into an abnormal cellular environment triggers
additional events that produce further damage of cells.
Manifests the ischaemic-reperfusion (IR) injury which
refers to myocardial, vascular and electrical dysfunction
[2-6]. Clinical manifestations of the IR injury include:
1. Injury of anatomical and functional integrity of
microcirculation, causing the no-reflow phenomenon -
inadequate myocardial perfusion of a given coronary
segment without angiographic evidence of mechanical
vessel obstruction [7-12].
2. Myocardial stunning, which refers to transient dys-
function of myocardium contractility. It results from
alterations in contractile proteins due to oxidant stress
and/or disturbed cellular calcium homeostasis [13-17].
3. Extension of the infarct zone.
4. Reperfusion arrhythmias (life threatening
arrhythmias).
There are several explanations for the impairment of
myocardial microcirculation: the plugging of distal seg-
ments of the coronary artery tree by microemboli of
thrombotic or atherosclerotic debris; endothelial dys-
function which includes increased expression of adhe-
sion molecules, selectins and release of vasoactive
substances, resulting in vasoconstriction; increased acti-
vation of platelets, neutrophils, the complement system
and inflammation; intensified generation of oxygen-free
radicals, increased membrane permeability and swelling
of endothelial cells and myocites, apoptosis and necrosis
of cardiomyocites [18-22]. All these mechanisms can
cause microvascular and myocardial dysfunction,
deranged myocardial metabolism and more extensive
myonecrosis. Previous studies indicate that patients with
no-reflow have an increased infarct size, impaired recov-
ery of LV function and poor short- and long-term prog-
nosis [23-29].
The early evaluation of myocardial reperfusion by
transthoracic Doppler echocardiography and single-
photon emission computed tomography (SPECT) in
AMI provides important clues for predicting patient’s
prognosis [30-32]. The total perfusion defect (TPD)
detected by SPECT indicates the extent of no-reflow in
the infarct area after reperfusion in AMI and the final
infarct size at the follow-up period. The final infarct size
is a sensitive end point and can be used to estimate the
effectiveness of reperfusion therapy in AMI and to
associate with subsequent patient mortality [33-38].
The measurement of CFR by TDE has recently
entered the stress echo laboratory [39-45]. CFR is
expressed as a ratio of hyperaemic to basal peak diasto-
lic coronary flow velocity (Figure 1). The CFR cut-off
value of 2 for detecting significant epicardial coronary
stenosis and for predicting ischaemia has been demon-
strated in various studies. In patients with normal epi-
cardial arteries CFR reflects both structural and
functional integrity of the microvasculature in the myo-
cardium. Previous studies revealed that the measure-
ment of CFR in the IRA might reflect a greater degree
of microvascular damage in the infarct area, predict
myocardial viability and LV remodelling after AMI
[46-56]. However, the mean value of CFR varies widely
Figure 1 Coronary flow by spectral Doppler. The greater component during diastole and the smaller component during systole at rest (A)
and during hyperaemia (B). CFR = b/a. CFR > 2 (an example of normal CFR).
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population studied, the presence and extent of risk fac-
tors for vascular dysfunction, the concomitant medical
therapy before the test. Moreover, in many cases the
efficacy of the reperfusion therapy was assessed quite
early after PCI before microvascular damage reached a
peak after the reperfusion [57-59]. Therefore, there is no
clear cut-off value of CFR during the acute MI phase for
the prediction of local and global LV function recovery
and the final infarct size.
The aim of our study was to evaluate the association
of coronary flow reserve assessed 72 hours after reper-
fused AMI with myocardial reperfusion and to estimate
CFR predictive value for LV functional recovery, myo-
cardial viability and the final infarct size at follow-up.
Methods
Study population
The sample of the study was sellected by purposive
sampling: all the enrolled patients were treated in the
Intensive Care Unit (ICU) of the Department of Cardio-
vascular Medicine, Vilnius University Hospital Santaris-
kiu Klinikos from February 2008 till September 2010
and fulfilled the inclusion criteria. Totaly 44 patients (6
woman and 38 men, aged 25 - 65 years) were studied.
All the patients were with the first anterior STEMI with-
out prior angina pectoris. Inclusion criteria were typical
anginal chest pain lasting ≥ 30 min, ST-segment eleva-
tion of > 0.2 mV in at least two contiguous electrocar-
diographic leads, ≥ 3-fold increase in serum creatine
kinase (CK) or Troponin I level, angiographically docu-
mented single vessel disease with the occluded left ante-
rior descending coronary artery (LAD), with TIMI flow
grade 0 - 1 before PCI and TIMI flow grade 3 after PCI.
Exclusion criteria were pregnancy, lactation, unstable
condition, more than one coronary artery disease, resi-
dual LAD stenosis after intervention > 20%, previous
myocardial infarction and/or coronary revascularisation,
second or third degree atrioventricular block, severe
valve disease, systolic blood pressure < 90 mm Hg,
bronchial asthma or chronic obstructive pulmonary
disease.
Study design
All the patients underwent revascularization of the LAD
by PCI and stent placement using standard technique
within 12 hours after the onset of chest pain. Contrast
flow through the IRA was graded by the means of the
TIMI flow classification. Collateral flow was graded
according to the Rentrop classification [60]. 31 patients
(70.45%) showed poor or no collateral flow (Rentrop
grade 1 or 0) on the initial coronary angiogram. Proce-
dural success was defined as TIMI flow 3 and residual
stenosis ≤ 20% in the IRA.
Immediately after PCI, two-dimensional echocardio-
graphy (2D Echo) was performed in all the patients in
the ICU. LV ejection fraction (LVEF), end-diastolic
volume (EDV), end-systolic volume (ESV) were com-
puted by the Simpson biplane method and wall motion
score index (WMSI) was calculated using the standard
16-segment LV model [61]. Imaging was performed
using the Vivid S5 System (GE Healthcare, USA).
The 12-lead electrocardiograms (ECGs) were obtained
at the admission, in an hour, 6 hours and 12 hours after
the reperfusion. Blood sampling for serum markers of
myonecrosis (CK, CK-MB, Troponin I) was routinely
taken at the admission, 6 hours, 12 hours and 24 hours
after the admission to estimate the peak concentration
of these markers.
All the patients underwent 3D Echo, dobutamine stress
echocardiography (DSE), CFR, SPECT evaluation 72 hours
after the reperfusion. First of all, we performed 3D Echo.
Shortly, the myocardial contractility was examined by low-
dose dobutamine echocardiography (LDDE). On the same
day, several hours after LDDE, adenosine intravenous infu-
sion was administered at a rate 140 μg/kg/min for six min-
utes for CFR evaluation and for gated-SPECT stress
imaging. Spectral Doppler signals of the coronary flow in
the distal portion of the LAD were recorded 60 s after the
onset of the infusion for CFR off-line analysis. Afterwards,
the infusion of adenosine was continued for myocardial
perfusion stress imaging. Myocardial perfusion rest images
were obtained one day later. The patients were offered
chocolate milk to drink before acquisition in order to
diminish bowel artefacts. Examinations were performed in
the fasting state. Beta-blockers and nitrates were discon-
tinued for 48 hours. No side effects occurred during these
procedures. The same examinations were repeated for all
the patients at 5 month follow-up.
All the patients gave written informed consent. Study
conformed to the principles outlined in the Declaration
of Helsinki. Approval of the Lithuanian Bioethics Com-
mittee was granted (permission No.2/109, 2008-02-10).
Electrocardiographic studies
An ECG was recorded using the Page Writer Trim III
(Philips Medical Systems 3000, Andover, USA). The ST-
segment elevation (60 ms from the point J) was mea-
sured in the single lead (I,a V L ,V 1 - V 6 )w i t hm a x i m a l
elevation. The normalization of ST-segment elevation
during 1 hour after PCI comparing with the initial ECG
was calculated according to the formula:
100% −

ST − elevationafter PCI/ST − elevationbefore PCI

x 100%
The ST-segment resolution ≥ 70% was defined as
complete resolution, 30-70% - partial resolution and <
30% - no resolution of the ST-segment.
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Real-time 3D Echo harmonic imaging was performed
using the V i v i d7D i m e n s i o nU l t r a s o u n dS y s t e m( G E
Healthcare, USA) equipped with a V3 matrix-array
transducer. The digital real-time 3D echocardiographic
LV data sets were analyzed off-line using Tom Tec’s4 D
LV Function software by semi-automatic detection of
LV contours. LVEF, EDV, ESV were computed.
CFR measurements by transthoracic Doppler
echocardiography
The assessment of CFR by TDE was performed using
the Vivid 7 Dimension ultrasound system (GE Health-
care, USA) with second harmonic technology. For colour
Doppler (3 MHz) flow mapping, the velocity range was
s e ta t1 2t o2 0c m / s .C o r o n a r yf l o wv e l o c i t yw a sm e a -
sured with pulsed wave Doppler at 2.8 MHz (sample
volume 2.0 mm) using colour Doppler (CD) as a guide.
The angle correction was performed if the angle
between the flow and the Doppler beam exceeded 20
degrees and was maintained during rest and stress stu-
dies. The spectral trace of the coronary flow was charac-
teristically biphasic with a dominating diastolic
component.
The patients were examined in the left position. We
recorded the flow in the most distal part of the LAD. A
short axis view of the LV and the anterior groove was
interrogated with CD. When diastolic CD blood flow
was detected, the transducer was slowly rotated clock-
wise to obtain the best long axis view of the LAD.
First of all, we recorded baseline spectral Doppler sig-
nals in the distal portion of the LAD. Then, spectral
Doppler signals were recorded during hyperaemic condi-
tions (60 s after the onset of the infusion of adenosine).
Stop frames and clips were digitally recorded for off-line
analysis. Recordings were done during a brief period of
holding breath. The images were interpreted by 2
experienced physicians. Measurements were averaged
over three consecutive heart beats. The peak diastolic
flow velocity was measured at baseline and at peak
hyperaemic conditions. CFR was defined as the ratio of
hyperaemic to basal peak diastolic coronary flow velocity
(Figure 2).
Dobutamine stress echocardiography
DSE studies were performed with Vivid 7 Dimension
ultrasound system (GE Healthcare, USA).2 DE c h oa n d
12-lead ECG monitoring were performed with low-dose
dobutamine infusion. The standard dobutamine stress
protocol consisted of continuous intravenous infusion of
dobutamine in 3 minutes increments, starting with 5
μg/kg/min and increasing to 10 μg/kg/min. Echo images
(apical four- and two-chamber, parasternal long- and
short-axis views) were semiquantitatively assessed by 2
experienced physicians using a 16-segment LV model, a
wall motion four-grade scale model in resting condition,
each stage thereafter and during the recovery phase. We
estimated WMSI. In the non-viability response (without
contractile reserve), a segment with resting dysfunction
remained fixed during stress. If the improvement of wall
motion was present in at least four contiguous dysfunc-
tional segments by ≥ 1 grade or WMSI decrease ≥ 0.25
during low-dose dobutamine infusion, they indicated the
presence of the stunned myocardium with preserved
contractile function which is the predictor of segmental
functional recovery at the follow-up period [62]. When
DSE was repeated 5 months later, the dose of dobuta-
mine infusion was gradually increased every 3 minutes
starting from 5 μg/kg/min to 10, 20, 30 and 40 μg/kg/
min. Higher doses were used in order to discriminate
between the hibernating (ischaemic) myocardium and
myocardial stunning.
Single-photon emission computed tomography
Gated-SPECT studies were performed using a two-day
stress/rest protocol with a dual-detector gamma camera
INFINIA GP 3 (GE Medical Systems, USA).
99 m Techne-
tium (Tc) tetrofosmin (750 MBq) was injected
Figure 2 An example of impaired CFR. Coronary flow by spectral Doppler at rest (A) and during hyperaemia (B). CFR < 1.5, estimated in the
patient with absence of myocardial viability and with extensive myocardial perfusion defect.
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nosine. Supine electrocardiographically gated-SPECT
images were acquired after 45 minutes. Rest images
were obtained one day later using the same radioactivity
of
99 m Tc tetrofosmin with acquisition starting 60 min-
utes after the injection. The gated and non-gated data
were separately reconstructed on a workstation for off-
line analysis. No scatter or attenuation correction was
applied. The images were interpreted by 2 experienced
physicians. We performed both visual semiquantitative
analysis, which accounts for a variety of artefactual pat-
terns that can be recognized only by visual inspection,
and automatic quantitative computer-generated analysis.
An investigator evaluated visually all images by
intensity of myocardial colour-coded scintillation,
which depends on the uptake of the radiotracer. The
entire LV myocardium was divided into 20 segments.
Each segment was scored using a five-point system:
the score 0 was used for normal perfusion, i.e. the
uptake of the radiotracer was not disturbed; 1 - perfu-
sion was slightly reduced (slight reduction of the
uptake); 2 - moderate reduction of the uptake; 3 -
severe reduction of the uptake; 4 - no perfusion. Using
special software package QPS (Cedar Sinai Medical
Center, Los Angeles, CA, USA) fully automated quanti-
tative analysis of myocardial perfusion was carried out
from “bull’s eye” (polar map) images: combined exten-
sion and severity of the perfusion defect in one vari-
able - the total perfusion defect in% (TPD%) - was
defined at stress and at rest imaging. We referred that
T P D<5 %t ob en o r m a l ,b e t w e e n5a n d9 %w a s
termed mild, 10-15% - moderate, and > 15% - severe.
We assessed the success of myocardial reperfusion as
the TPD (corresponding to final infarct size) by
repeated SPECT at follow-up after 5 months.
Statistical analysis
The statistical analysis was performed with the use of
the SPSS software package for Windows 17.0. Data were
expressed as mean ± standard deviation (SD) or number
(%) of patients. The Receiver Operating Characteristic
(ROC) curve analysis was performed to determine test
sensitivity and specificity based on CFR. The test perfor-
mance was estimated by calcul a t i n gt h ea r e au n d e rt h e
curve (AUC). The optimal cut-off value of CFR was
defined as that providing the maximal accuracy to dis-
tinguish between the patients with preserved and
impaired CFR during the acute MI phase.
Categorical data were compared by an c
2 (chi square)
analysis, continuous variables were analysed with the
independent Student’s t test. In order to compare
WMSI changes separately in the subgroups of patients
with preserved and impaired CFR 72 hours after the
reperfusion, at LDDE and at follow-up Echo, paired
samples t test was conducted. A value of p < 0.05 was
considered to be significant.
In order to analyse correlation between CFR and con-
tractile reserve at LDDE, LVEF, TPD at rest and at
stress in the infarct area 72 hours after reperfusion and
at 5 months follow-up, the Pearson correlation analysis
was conducted.
The linear regression analysis was used to assess the
relationship between CFR evaluated 72 hours after PCI
and preserved myocardial contractility (viability) as well
as the final infarct size.
Results
The estimation of the optimal CFR cut-off value in order
to distinguish between patients with preserved and
impaired CFR
The ROC analysis was performed to estimate test sensi-
tivity and specificity based on a wide range of cut-off
points of CFR for the detection of myocardial viability,
spontaneous LV functional recovery and a moderate
final infarct size. For the evaluation of LV segmental
functional recovery, the decrease of WMSI ≥ 0.25 at
LDDE during the acute MI phase and at 5 months fol-
low-up echocardiography (as compared to the acute
phase echocardiography) was described as a marker of
myocardial viability and spontaneous functional recov-
ery. The TPD ≤ 15% was defined as a moderate final
infarct size after reperfused MI at follow-up. We esti-
mated the optimal CFR cut-off value of 1.75 as provid-
ing the maximal accuracy to distinguish between
patients with preserved CFR (N = 19) and impaired CFR
(N = 25) during the acute MI phase (sensitivity 91.7%,
specificity 75%). The AUC was 0.88 ± 0.1 (p < 0.001)
(Figure 3).
The comparison of the subgroups with preserved and
impaired CFR
According to the estimated CFR cut-off value all the
patients were divided into two subgroups. Clinical his-
tory, risk factors, anti-ischaemic therapy before AMI
and angiographic characteristics in both subgroups did
not differ significantly, with the exception of timing to
reperfusion and ECG ST-segment complete resolution
in patients with preserved and impaired CFR (Table 1).
The majority of patients with preserved CFR (94.8%)
received PCI during 6 hours after the onset of chest
pain as compared to 56% of patients with impaired CFR.
On the contrary, only 5.2% of patients with preserved
CFR received PCI after 6 hours from the onset of chest
pain as compared to 44% of patients with impaired CFR
(p = 0.011). Thus, the timing of reperfusion is very
important for the maintenance of the intact microvascu-
lature of the myocardium during AMI. We also revealed
statistical difference of ECG ST-segment complete
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than 47% of patients with preserved CFR had complete
ST-segment regression during 1 hour after PCI as com-
pared to 16.7% of patients with impaired CFR (p =
0.033).
According to these results we can state that an incom-
plete ST-segment resolution correlates with impaired
structural and functional integrity of microcirculation
and suboptimal myocardial reperfusion.
Relationship between CFR, myocardial contractile reserve
(viability) and SPECT reflow
In order to analyse the correlation between CFR
assessed 72 hours after reperfusion and the parameters
of LV function and perfusion during the acute MI phase
and at 5 months follow-up the Pearson correlation coef-
ficient was calculated (Table 2, Figure 4).
A moderate direct correlation between CFR and pre-
served contractile reserve was observed during the acute
MI phase (r = 0.626, p < 0.001) and at follow-up (r =
0.680, p < 0.001), also with spontaneous segmental (r =
0.559, p < 0.001) and global LV (r = 0.373, p < 0.05)
functional recovery at the follow-up. CFR was inversely
correlated with the TPD which was an indicator of ana-
tomical and functional microvascular integrity and no-
reflow extent in the infarct area after reperfusion at rest
Figure 3 The ROC analysis for CFR.
Table 1 Clinical and angiographic characteristics in two subgroups of the patients with preserved and impaired CFR
Characteristics Preserved CFR (N = 19) Impaired CFR (N = 25) p value
Age 50.26 (8.46) 51.76 (10.78) 0.620
Gender Men 16 (84.2%) 22 (88.0%) 0.525
Cigarette smoking 11 (57.9%) 13 (52.0%) 0.467
Hypertension 12 (63.2%) 17 (68.0%) 0.492
Hypercholesterolemia 19 (100%) 25 (100%) -
Obesity 5 (26.3%) 9 (36.0%) 0.363
ACE inhibitors 6 (31.6%) 5 (20.0%) 0.298
Beta-blockers 4 (21.1%) 8 (32.0%) 0.323
Aspirin 1 (5.3%) 3 (12.0%) 0.415
Diuretics 2 (10.5%) 2 (8.0%) 0.585
Nitrates 0 1 (4.0%) 0.568
Peak CK-MB (U/l) 208.64 (272.20) 428.14 (565.51) 0.127
Peak Troponin I (μg/l) 76.11 (102.66) 130.00 (102.49) 0.084
Time interval from the onset of chest pain to PCI 0-3 hours 12 (63.2%) 7 (28.0%)
3-6 hours 6 (31.6%) 7 (28.0%) 0.011
> 6 hours 1 (5.2%) 11 (44.0%)
ECG ST-segment complete resolution (≥ 70%) during 1 hour after PCI 9 (47.4%) 4 (16.7%) 0.033
TIMI flow grade before PCI I* 2 (10.5%) 1 (4.0%) 0.396
No flow 17 (89.5%) 24 (96.0%)
Collaterals 6 (31.6%) 7 (28.0%) 0.528
Data are mean (SD) or number (%) of patients.
ACE - angiotensin converting enzyme; CK - creatine kinase; PCI - percutaneous coronary intervention; ECG - electrocardiography; TIMI - Thrombolysisi n
Myocardial Infarction; LAD - left anterior descending coronary artery, AMI - acute myocardial infarction.
Sadauskiene et al. Cardiovascular Ultrasound 2011, 9:16
http://www.cardiovascularultrasound.com/content/9/1/16
Page 6 of 13(r = -0.541, p < 0.001) and at stress imaging (r = -0.492,
p < 0.001). Also CFR was inversely correlated with the
final infarct size assessed as the TPD at follow-up (r =
-0.620, p < 0.001). Most significant correlations were
observed between early assessed CFR and the TPD at
rest (r = -0.620, p < 0.001) and at stress imaging (r =
-0.636, p < 0.001) after 5 months, also with contractile
reserve during the acute MI phase (r = 0.626, p < 0.001)
and at follow-up (r = 0.680, p < 0.001). There was no
statistically significant correlation between CFR and
WMSI at rest, LVEF and ESV during the acute MI
phase, while correlation between CFR and these para-
meters was observed after 5 months (r = -0.567, r =
0.373 and r = -0.363, p < 0.05, respectively).
According to these data from our study, CFR mea-
sured non-invasively 72 hours after reperfused AMI is
an indicator of microvascular integrity and function (the
extent of no-reflow), segmental and global LV functional
recovery, myocardial viability and the final infarct size.
The comparison of the parameters of LV function and
perfusion in preserved and impaired CFR subgroups
In order to compare the parameters of LV function and
perfusion during the acute MI phase and at the follow-
up period in preserved and impaired CFR groups, we
performed the independent Student’s t test analysis
(Table 3).
Patients with preserved CFR had a statistically signifi-
cant smaller TPD than patients with impaired CFR: the
TPD was 12.58% (1.22) vs. 30.16% (11.32) (p < 0.001) at
rest and 19.68% (12.77) vs. 37.76% (11.59) (p < 0.001) at
stress myocardial perfusion imaging during the acute MI
phase; the final infarct size was 5.26% (6.14) vs. 23.28%
(12.19) (p < 0.001) at rest and 8.74% (9.44) vs. 28.12%
(9.72) (p < 0.001) at stress imaging after 5 months,
respectively.
Global LV systolic function (LVEF as assessed by 3D
Echo) was significantly better in patients with preserved
than in patients with impaired CFR: 47.78% (8.99) vs.
40.79% (7.25) (p = 0.007) during the acute MI phase
and 49.78% (8.70) vs. 40.36% (7.90) (p = 0.001) at fol-
low-up.
Wall motion and contractility did not improve signifi-
cantly in patients with impaired CFR with WMSI chan-
ging from 1.89 (0.17) 72 hours after PCI to 1.80 (0.21)
at LDDE (p = 0.138) and to 1.81 (0.20) at follow-up
Echo (p = 0.159). In the group with preserved CFR,
WMSI changed significantly from 1.74 (0.29) 72 hours
after PCI to 1.48 (0.27) at LDDE (p = 0.009) and to 1.47
(0.30) at the follow-up period (p = 0.008).
Thus, the viable myocardium, spontaneous regional
and global LV functional recovery, the smaller no-reflow
zone and the final infarct size were more common in
patients with preserved CFR than in patients with
impaired CFR.
Relationship between CFR, myocardial viability and the
final infarct size
The computed linear univariate regression showed an
inverse correlation between CFR assessed 72 hours after
AMI and the final infarct size (r = -0.620; R square =
0.385, y = -39.717 x CFR + 83.235), e.g. if a patient’s
CFR was the same as our study cut-off value of 1.75, the
final infarct size was 13.92%. Linear regression also
showed statistically significant relation between CFR and
preserved contractility (r = -0.680; R square = 0.462, y =
0.751 x CFR - 1.015), e.g. if the patient’sC F Rw a st h e
same as our study cut-off value of 1.75, the difference
between WMSI at rest and WMSI at LDDE was 0.2954.
Finally, we analysed the strength of the relationship
between early assessed CFR, the final infarct size and
Table 2 Correlation between CFR and parameters of LV
function and perfusion
Parameters of LV function and perfusion Correlation coefficient
(r)
72 hours after the reperfusion
TPD at stress (%) -0.492**
TPD at rest (%) -0.541**
LVEF (%) (3D) 0.267
LV ESV (ml) (3D) -0.219
LV EDV (ml) (3D) -0.314*
WMSI at rest -0.295
WMSI LDDE -0.552**
At 5 months follow-up
CFR 0.505**
TPD at stress (%) -0.636**
TPD at rest (%) -0.620**
LVEF (%) (3D) 0.373*
LV ESV (ml) (3D) -0.363*
LV EDV (ml) (3D) -0.349*
WMSI at rest -0.567**
WMSI LDDE -0.671**
Contractile reserve (difference ≥ 0.25 of WMSI)
WMSI at rest (AMI) - WMSI at rest (at follow-
up)
0.559**
WMSI at rest (AMI) - WMSI LDDE (AMI) 0.626**
WMSI at rest (AMI) - WMSI LDDE (at follow-
up)
0.680**
*p < 0.05; **p < 0.001
CFR - coronary flow reserve; LV- left ventricular; LVEF - left ventricular ejection
fraction; LV ESV - left ventricular end-systolic volume; LV EDV - left ventricular
end-diastolic volume; 3D - three-dimensional echocardiography; WMSI - wall
motion score index; WMSI LDDE - wall motion score index at low-dose
dobutamine echocardiography; WMSI at rest - WMSI LDDE - difference ≥ 0.25
between WMSI at rest and WMSI at LDDE indicates the presence of contractile
reserve; WMSI at rest (AMI) - WMSI at rest (at follow-up) - difference of WMSI
≥ 0.25 indicates the myocardial viability; TPD% - total perfusion defect (%)
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Page 8 of 13myocardial viability (Table 4). The sensitivity varied
from 77% to 92% and the specificity - from 66% to 91%.
The positive predictive value varied from 50% to 89%
and the negative predictive value - from 80% to 95%.
According to these data we concluded that preserved
CFR during the acute MI phase can predict the preserved
myocardial contractility and viability (spontaneous LV
functional recovery) and the smaller final infarct size at
the follow-up period.
Discussion
The no-reflow phenomenon was first explored by Ito et al.
[25] in patients with anterior AMI after mechanical or
pharmacologic revascularization. This phenomenon
Table 4 The relationship between CFR, the final infarct size (TPD) and myocardial viability at follow-up
TPD
yes
≤15%
no
Positive predictive value Negative predictive value Sensitivity Specificity
CFR ≥ yes 17 2 0,89 0,80 0,77 0,91
1.75 no 5 20
Myocardial viability
yes no
CFR ≥ yes 10 9 0,52 0,92 0,83 0,72
1.75 no 2 23
Myocardial viability
yes no
TPD ≤ yes 11 11 0,50 0,95 0,92 0,66
15% no 1 21
CFR - coronary flow reserve; TPD - total perfusion defect; the difference between WMSI (at rest) during AMI and WMSI (at rest) at follow-up ≥ 0.25 indicates the
myocardial viability
Table 3 Comparison of the parameters of LV function and perfusion in two subgroups
Parameters of LV function recovery Preserved CFR (N = 19) Impaired CFR (N = 25) p value
72 hours after reperfusion
TPD at stress (%) 19.68 (12.77) 37.76 (11.59) < 0.001
TPD at rest (%) 12.58 (1.22) 30.16 (11.32) < 0.001
LVEF (%) (3D) 47.78 (8.99) 40.79 (7.25) 0.007
LV ESV (ml) (3D) 64.32 (22.97) 74.86 (16.11) 0.084
LV EDV (ml) (3D) 109.06 (21.90) 128.10 (24.15) 0.011
WMSI at rest 1.74 (0.29) 1.89 (0.17) < 0.001
WMSI LDDE 1.48 (0.27) 1.80 (0.22) < 0.001
At 5 months follow-up
CFR 2.61 (0.40) 2.06 (0.33) < 0.001
TPD at stress (%) 8.74 (9.44) 28.12 (9.72) < 0.001
TPD at rest (%) 5.26 (6.14) 23.28 (12.19) < 0.001
LVEF (%) (3D) 49.78 (8.70) 40.36 (7.90) 0.001
LV ESV (ml) (3D) 59.28 (2.18) 80.04 (25.10) 0.006
LV EDV (ml) (3D) 113.39 (25.28) 133.72 (3.59) 0.026
WMSI at rest 1.47 (0.30) 1.81 (0.20) < 0.001
WMSI LDDE 1.30 (0.28) 1.76 (0.25) < 0.001
Contractile reserve (difference ≥ 0.25 of WMSI)
WMSI at rest (AMI) - WMSI at rest (at follow-up) 0.27 (0.19) 0.07 (0.10) < 0.001
WMSI at rest (AMI) - WMSI LDDE (AMI) 0.25 (0.13) 0.08 (0.09) < 0.001
WMSI at rest (AMI) - WMSI LDDE (at follow-up) 0.43 (0.20) 0.13 (0.16) < 0.001
Data are mean (SD)
CFR - coronary flow reserve; LV- left ventricular; LVEF - left ventricular ejection fraction; LV ESV - left ventricular end-systolic volume; LV EDV - left ventricular end-
diastolic volume; 3D - three-dimensional echocardiography; WMSI - wall motion score index; WMSI LDDE - wall motion score index at low-dose dobutamine
echocardiography; WMSI at rest - WMSI LDDE - difference ≥ 0.25 between WMSI at rest and WMSI at LDDE indicates the presence of contractile reserve; WMSI at
rest (AMI) - WMSI at rest (at follow-up) - difference of WMSI ≥ 0.25 indicates the myocardial viability; TPD% - total perfusion defect (%)
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Page 9 of 13predicted worse LV functional recovery, increased the risk
of the post-infarction complications and poor clinical out-
comes [23]. Various subsequent studies [63-67] have proved
that preserved microcirculation and reflow after reperfused
AMI predict the viable myocardium and the recovery of LV
function. Comprehensive and comparative evaluation of dif-
ferent parameters of LV function and perfusion during the
acute MI phase and at follow-up was not reported in the lit-
erature. Thus, our study is the first complex attempt to
assess the influence of impaired microvascular integrity and
function as well as the extent of no-reflow on LV contracti-
lity, spontaneous functional recovery and the final infarct
size by modern, non-invasive techniques.
Previous studies highlighted the importance of non-
invasive analysis of CFR in predicting LV functional
recovery after coronary reperfusion in AMI
[49,51,63,65-67]. However, in all these studies there
were no clear cut-off values of CFR, because the mean
value of CFR varied widely in different studies due to
the heterogeneity of each population studied, different
timing of the myocardial reperfusion and the CFR test,
residual stenosis after PCI [55,57-59,68]. Therefore, the
two subgroups of our study were similar by clinical,
medical and angiographic characteristics.
Due to the progression of microvascular damage and
reactive hyperaemia after reperfusion in AMI, timing of
CFR assessment is very important. Lepper et al. [64]
f o u n das i g n i f i c a n tC F Ri m p r o v e m e n ta t2 4h o u r sa f t e r
reperfused AMI as compared to CFR performed imme-
diately after primary PCI. Rochitte et al. [57] showed
that microvascular damage had developed progressively
up to 48 hours after reperfusion and stabilized after two
days. Accordingly we evaluated myocardial reperfusion
by TDE as the CFR measurement and by SPECT as the
TPD size 72 hours after successful primary PCI for ante-
rior AMI when microvascular damage after infarction
was stable.
The optimal cut-off value of 1.75 to predict myocardial
viability, spontaneous LV functional recovery and a mod-
erate final infarct size was proven as that providing the
maximal accuracy to distinguish the patients with pre-
served and impaired CFR. As we predicted, there were
differences comparing patients with preserved and
impaired CFR according to the time interval from the
onset of chest pain to reperfusion. These data was con-
firmed in other experimental and clinical studies
[5,28,29], suggesting that more prolonged and severe
ischaemia causes more severe microvascular dysfunction.
Electrocardiographic analysis of ST-segment resolution
is one of the simplest and most widely used criterion to
assess the effectiveness of restoration of antegrade cor-
onary flow in the IRA and predicts not complicated
post-infarction course [69]. However, for a long time
there were no clinical studies investigating correlation of
ST-segment normalization with the restoration of blood
flow in the microvascular bed (tissue reperfusion) and LV
functional recovery after reperfused MI. In the multicen-
tre AMICI (Acute Myocardial Infarction Contrast Ima-
ging) trial [70] the investigators found that only TIMI
flow grade < 3 and echo contrast defect > 25% were inde-
pendently associated with LV remodelling at the follow-
up period, while ST-segment reduction > 70% was not
different between the two groups with and without LV
remodelling. These findings were similar in other studies
[71,72]. In our study 47.4% of patients with preserved
CFR had complete ST-segment regression during 1 hour
after PCI as compared respectively to 16.7% patients in
the impaired CFR group (p = 0.033). Consequently, the
clinical value of ST-segment normalization still remains
an object of scientific discussions. According to the data
from our study we can conclude that ECG ST-segment
normalization is a good indicator of successful tissue
reperfusion, but more extensive evaluation is necessary
to estimate microvascular integrity and to predict LV
functional recovery, the final infarct size and, conse-
quently, a patient’s prognosis.
Study limitations
Our study has been limited by a relatively small number of
patients. However, the two study subgroups were quite
homogeneous, so the results should be widely applicable.
CFR assessment by TDE is a simple, non-invasive techni-
que to obtain the diastolic flow and its velocity in the LAD
with the success rate of 90-96%. However, the success rate
to obtain the diastolic flow in the right coronary artery is
34-50% and in the circumflex coronary artery - 60-80%,
thus restricting its application. Besides, we used dobuta-
mine-induced contractility and wall motion recovery dur-
ing the acute MI phase and at the follow-up period as
indicators of myocardial viability. This approach has been
based on semiquantitative analysis, therefore has some lim-
itations when compared with positron emission tomogra-
phy or magnetic resonance imaging with contrast
(quantitative analysis of myocardial perfusion and viability).
Conclusions
The early, non-invasive measurement of CFR by TDE
provides insight into the pathophysiological changes of
microcirculatory integrity and function after reperfused
AMI. We revealed that CFR measurement can be of
high value for the assessment of successful reperfusion
in AMI. The preserved CFR with the cut-off value of
1.75 during the acute MI phase can predict the LV func-
tional recovery, myocardial viability and a moderate final
infarct size (TPD ≤ 15%) at follow-up with high sensitiv-
ity and specificity (91.7% and 75%, respectively). Besides,
the combination of the myocardial perfusion test by
CFR and SPECT studies as well as the analysis of LV
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Page 10 of 13wall motion abnormalities by LDDE represent the eva-
luation of the flow-function relationship. Concordant
contractility and myocardial perfusion results enhance
the diagnostic accuracy in the prediction of LV func-
tional recovery after reperfused AMI. Furthermore, the
CFR study adds quantitative information to the qualita-
tive assessment of wall motion analysis.
Thus, early assessment of CFR by TDE provides
important prognostic information in patients with recent
myocardial infarction and should be integrated in the
routine evaluation of these patients.
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